Robert Shawah
Gründer bei ACURX PHARMACEUTICALS, INC.
Vermögen: 474 892 $ am 31.05.2024
Aktive Positionen von Robert Shawah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Gründer | 01.07.2017 | - |
| Finanzdirektor/CFO | 01.07.2017 | - | |
| Comptroller/Controller/Auditor | 01.07.2017 | - |
Karriereverlauf von Robert Shawah
Ehemalige bekannte Positionen von Robert Shawah
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Ameri100 Holdco, Inc.
 Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Direktor/Vorstandsmitglied | 01.08.2018 | 01.12.2018 |
Dipexium Pharmaceuticals, Inc.
 Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01.03.2014 | 01.04.2017 |
| Treasurer | 01.03.2014 | 01.04.2017 | |
| Baldwin Pearson & Co., Inc. | Corporate Officer/Principal | 01.01.2005 | 01.01.2013 |
Ausbildung von Robert Shawah
| Bucknell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Miscellaneous | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ACURX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Dipexium Pharmaceuticals, Inc.
Dipexium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dipexium Pharmaceuticals, Inc. is a late stage pharmaceutical company, which is focused on the development and commercialization of Locilex, a potent and broad spectrum topical antibiotic peptide for the treatment of mild and moderate skin and skin structure infections. The company was founded by Robert J. DeLuccia and David P. Luci on January 14, 2010 and is headquartered in New York, NY. | Health Technology |
| Baldwin Pearson & Co., Inc. | |
Ameri100 Holdco, Inc.
Ameri100 Holdco, Inc. MiscellaneousMiscellaneous Ameri100 Holdco, Inc. operates as an investment holding company. The company is headquartered in Delaware. | Miscellaneous |
- Börse
- Insiders
- Robert Shawah
- Erfahrung
